Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

With Black Friday Coming Up, Why Not Book a Trip to Sweden?

Just Make Sure You Don’t Go to Switzerland Instead!   A recent study commissioned by Visit Sweden revealed that 50 percent of respondents in America were not sure what the difference is between Swedish and Swiss culture. So much so, that this has caused confusion (and sometimes even mistakes) while booking. In fact, 10 percent of respondents have booked (or nearly booked) a flight, tour, or activity for the wrong country!   Northern Lights. In Switzerland, you can enjoy some spectacular light shows made with projections and LED’s. In Sweden however, there’s no need

Notification of transactions by persons discharging managerial responsibilities and persons closely associated with them

Company Announcement no. 29/202322 November 2023 Wirtek A/S has received notification pursuant to article 19 of regulation (EU) no. 596/2014 of the below transactions related to shares in Wirtek A/S made by persons discharging managerial responsibilities and/or persons closely related with them. Wirtek’s board member Kent M. Sørensen has on 16 November 2023 acquired in total 5.345 shares at an average share price of DKK 9,4926 each for a total of DKK 50.737,78. Transaction: Name Holding Transaction Holding after transaction before

U.S. patent approval for Intervacc’s vaccine against infections caused by Streptococcus suis

Stockholm, November 22, 2023 – Intervacc AB (“Intervacc”) announces that the United States Patent and Trademark Office has granted an approval for Intervacc’s patent application in the United States for a vaccine against Streptococcus suis infections in pigs. The U.S. Patent No. 11,814,415 relates to a vaccine based on recombinant fusion proteins where patent protection is effective until 2037. Streptococcus suis (S. suis) is an endemic cause of disease that results in significant economic losses to the pig industry throughout the world. The bacterium is transmitted from sows to piglets

SBB announces successful completion of EduCo transaction with Brookfield

Samhällsbyggnadsbolaget i Norden AB (publ) (“SBB”) today completed its previously announced sale of 1.16% of SBB EduCo AB (“EduCo”) to Brookfield for approximately SEK 242 million. EduCo will repay part of its inter-company loan from SBB, resulting in SBB receiving approximately SEK 8 billion in cash. SBB works purposefully to optimise the conditions in its business areas. The strategic co-operation with Brookfield strengthens the opportunities for long-term value creation in the Education business area. The transaction contributes to strengthen SBB's financial position. For further

At SPS 2023 Rockwell Automation and its PartnerNetwork ecosystem show how collaboration fuels digital transformation

Partners will bring best-in-class solutions for holistic approach to optimizing productionNovember 15th, 2023 – Düsseldorf, Germany: Rockwell Automation Inc., the world's largest company dedicated to industrial automation and digital transformation, is showcasing its extensive PartnerNetwork[TM] ecosystem at SPS 2023. This powerful network complements Rockwell Automation’s technology offerings and domain expertise and provides customers with an integrated system of engineering specialists and suppliers that are leaders in the automation and manufacturing industry. At Rockwell Automation’

#23-365 Listing of Derivatives at NGM

Information about various derivatives that will be listed at NGM.For more details, see attached file. For further information concerning this NGM notice please contact NGM Listing department on listings@ngm.se. Nordic Growth Market NGM AB About NGMNordic Growth Market NGM AB (NGM) is an authorized stock exchange with operations in Sweden, Norway, Denmark and Finland. The exchange is a wholly-owned subsidiary of Boerse Stuttgart, the leading retail exchange in Germany. NGM offers a complete marketplace for exchange traded products and provides a complete platform for companies

CS MEDICA A/S: Release of 2022/2023 Q4 report, for the period July – September 2023, including an invitation to a live-streamed conference call on 5st December, at 11 AM CET.

CS MEDICA (”CS MEDICA” or the ”Company”) hereby releases its Q4 report for the period July – September 2023. Highlights of the period will be presented at a live-streamed conference call on Tuesday the 5st of December at 11 AM CET. The Q4 report is available as an attached document to this press release and on the Company's website (www.cs-medica.com). Below is a summary of the report.Performance highlights · In this fourth quarter of 2022/2023 (July – September 2023), CS MEDICA delivered net sales of tDKK 73 (9.255) meeting the revised goal of Net Sales Year-to-date of mDKK 1.  In the

Tokmanni Group Corporation: Managers' Transactions – Takoa Invest Oy

Tokmanni Group Corporation        Managers' Transactions        22 November 2023 at 5:15 pmPerson subject to the notification requirement Name: Takoa Invest Oy Position: Member of the Board/Deputy member (X) Legal person  (1):Person Discharging Managerial Responsibilities In Issuer Name: Seppo Saastamoinen Position: Member of the Board Issuer: Tokmanni Group Oyj LEI: 743700VMG6KWF0FW1560 Notification type: INITIAL NOTIFICATION Reference number: 44153/11/12 ____________________________________________ Transaction date: 2023-11-17 Venue: AQEA Instrument

Elos Medtech’s application for de-listing has been approved

Elos Medtech AB (publ)’s (“Elos Medtech” or the “Company”) application for de-listing has now been approved by Nasdaq Stockholm. The last day of trading in Elos Medtech’s shares on Nasdaq Stockholm will be 19 December 2023. As previously announced, Elos Medtech has applied for de-listing of the Company’s shares from Nasdaq Stockholm. Nasdaq Stockholm has now approved the application and resolved that the last day of trading will be 19 December 2023. For further information, please contact: Stefano Alfonsi, President and CEO, +44 772 04 98 342, email: stefano.alfonsi@elosmedtech.com

#23-102 Unit issue in Lumito AB

With the support of the authorization from the annual general meeting on May 25, 2023, the board of Lumito AB (the “Company”) has decided on a unit issue with preferential rights for the Company’s existing shareholders.   The last day of trading in the Company’s shares including the right to receive unit rights is November 23, 2023. The first day of trading in the Company’s shares excluding the right to receive unit rights is November 24, 2023. The record date is November 27, 2023.   The shareholders of the Company will receive one (1) unit right for each (1) share held per the

Rederiaktiebolaget Eckerö is a company with a participating interest undertaking in the Viking Line Group

Viking Line Abp OTHER INFORMATION TO BE PROVIDED IN ACCORDANCE WITH STOCK MARKET REGULATIONS, November 22, 2023. 5:00 p.m. Rederiaktiebolaget Eckerö is a company with a participating interest undertaking in the Viking Line Group As of November 22, 2023, Viking Line Abp’s shareholding in Rederiaktiebolaget Eckerö exceeds 20%. Viking Line Abp’s Board of Directors decided today that Rederiaktiebolaget Eckerö will be accounted for as a company with a participating interest undertaking using the equity method in the Viking Line Group’s financial accounts. A positive initial income

Cereno Scientific participates in the Nordic-American Healthcare Conference 2023 (NAHC) in New York City

Cereno Scientific (Nasdaq First North: CRNO B), a company developing innovative treatments for common and rare cardiovascular disease, today announced that the company will participate at the Nordic-American Healthcare Conference 2023 (NAHC) on December 6-7, 2023, in New York City, US. The event is presented by DNB//Back Bay, Nasdaq, Innovation Norway, and Business Sweden.Sten R. Sörensen, CEO, will attend the 8th Annual Conference NAHC 2023 in New York City. The event takes place over two days in New York City, and is an invitation-only event. NAHC brings together leading Nordic

Fighting global warming with tamarind polymers

Schutzen Chemical Group inspired by ISC3 for Sustainable Chemistry – Start-up wins ISC3 Innovation Award 2023If South Mumbai is flooded in seven years, 20 million people will lose their homes. The number of cases of cancer in children will rise by 37 percent this year. The mountains of garbage in his homeland are getting bigger and bigger. As one of eight finalists in the Innovation Challenge 2023 of the International Sustainable Chemistry Collaborative Centre  (ISC3), Raj Tanna

SSAB Launches Strenx® Certified Fabricator Network: Elevating Excellence in Structural High Strength Steel Fabrication

SSAB, a global leader in high-strength steel, is proud to announce the launch of the Strenx® Certified Fabricator, an exclusive initiative designed to recognize and promote excellence in the field of high strength steel fabrication. Strenx® Certified Fabricator connects a select group of fabricators with a proven ability to provide OEMs with state-of-the-art steel components and pre-fabricated structures. They have demonstrated exceptional skill and expertise in working with SSAB’s Strenx® performance steel.SSAB has so far appointed six certified fabricators: G E Mathis Company (US),

Axactor ASA: Mandatory Notification of Trade by Primary Insider

Oslo, 22 November 2023 Terje Mjøs Holding AS, a company controlled by Terje Mjøs (Chair of Board of Axactor ASA), has on 22 November 2023 acquired 50,000 shares in the Company at an average price of 4.92 per share. After this transaction Terje Mjøs controls 700,000 shares in the Company. Please refer to the attached notifications of transactions for further details. This information is subject to the disclosure requirements in Regulation EU 596/2014 article 19 number 3 and the Norwegian Securities Trading Act section 5-12.

Neste enables Emirates to operate world’s first Airbus A380 demonstration flight with one engine powered with 100% SAF

Neste Corporation, News, 22 November 2023  Photo: Emirates A380 taking off on 100% SAF. Source: EmiratesEmirates, one of the world’s largest international airlines, has become the first airline to operate an Airbus A380 demonstration flight with one of the aircraft’s four engines powered with Neste’s sustainable aviation fuel (SAF). Emirates’ flight demonstrates the potential of SAF as a more sustainable drop-in replacement for fossil-based jet fuel, matching its technical and chemical requirements. SAF can currently be used in up to 50% blends with conventional fossil jet fuel.

The Board of Directors of Nurminen Logistics Plc resolved on a new performance period for the performance share plan and a new performance share plan for the CEO

Nurminen Logistics Plc        Stock Exchange Release  22 November 2023, at 3.00. p.m THE PERFORMANCE PERIOD 2023–2025 OF THE PERFORMANCE SHARE PLAN 2022–2026 The Board of Directors of Nurminen Logistics Plc established a Performance Share Plan 2022–2026 in 2022 for the key employees of Nurminen Logistics Plc. The key terms of the Performance Share Plan were published in a stock exchange release on 5 July 2022. The Board of Directors of the company resolved on a new performance period for the Plan covering the financial years 2023–2025. The target group of the Plan for the

Directorate Change

22 November 2023 Marechale Capital plc (“Marechale” or the “Company”) Directorate Change Marechale Capital plc (AIM: MAC), an established City of London based corporate finance house with a long-term track record and a strong reputation for advising and financing high growth consumer brands, leisure, clean energy, mineral extraction and technology companies, announces that Lord Howard Flight, a Non-executive Director of the Company, has stepped down from his role with the Company with immediate effect due to reasons of ill health.   Lord Flight has been an invaluable member

UNION therapeutics A/S announces publication of results from the IASOS Phase 2b study of orismilast in psoriasis in Journal of the American Academy of Dermatology

· In the Phase 2b study, orismilast significantly reduced Psoriasis Area and Severity Index (PASI) compared with placebo from baseline to week 16 · 39.5% to 49.0% of patients treated with orismilast achieved PASI75 and 22.0% to 28.3% of patients achieved PASI90 · The clinical data supports the benefits of orismilast, a next-generation, high potency PDE4 B/D selective inhibitor · Orismilast is currently tested in an ongoing Phase 2b study in atopic dermatitis, and with recently reported positive topline Phase 2 results in hidradenitis suppurativa (HS)   Hellerup, Denmark,

East Capital Real Estate develops Estonia’s largest logistics and industry park in Rae municipality

East Capital Real Estate is developing the largest logistics and light industry park in Estonia. Future East Capital Park Rae – a 140,000-square-metre logistics and light industry centre – will be located on a 30-hectare land plot next to Tallinn.The first building completions for Park Rae are planned for early 2025, while the remainder of the timing will depend on market demand. “The plot of land we bought for the construction of the logistics park in 2021 is well-located, just 15 minutes by car from the centre of Tallinn, with excellent access to Tallinn Ring Road and Tartu Road. We have

SSAB Europe’s change negotiations end in Raahe

The change negotiations initiated by SSAB Europe’s Finland Business Unit in Raahe have concluded. The negotiations identified solutions that can deliver permanent cost savings of more than EUR 10 million annually in fixed costs. As a result of the negotiations, workforce reductions were avoided.Negotiations started in September primarily due to continued weak demand. The solutions found include, for example, the development of working practices, job rotation and increasing multi-skills. "Together we were able to add solutions to increase flexibility, mobility and versatility in the

There are no items matching the current filter
There are no more items matching the current filter
Back to top